What does the Citigroup maintained Buy mean for NVS analyst rating?

Citigroup maintaining Buy on **NVS analyst rating** means the firm still expects Novartis to outperform peers. The price target cut to CHF 132 is a technical adjustment, not a downgrade of the underlying view.

Did the Citigroup note change Novartis price target and when?

Yes. On **February 05, 2026** Citigroup lowered the Novartis price target to **CHF 132** from CHF 133 while keeping the Buy rating in place, per the published note.

How should investors interpret a small price target cut with a maintained Buy?

A small cut alongside a maintained Buy signals continued confidence in fundamentals. Investors should weigh the **NVS analyst rating** with valuation, upcoming catalysts, and personal strategy before acting.

Where can I find the full analyst note and earnings context?

The brief Citigroup note summary is on The Fly and the Q4 2025 earnings transcript is on Seeking Alpha. Use both to compare the **NVS analyst rating** with company guidance and commentary.

Analyst Ratings

Citigroup Maintains Buy on Novartis AG (NVS) Feb 2026, PT CHF132

ByDanny Kontos February 6, 2026

NVS analyst rating: Citigroup maintained a Buy on Novartis AG (NVS) on February 05, 2026, while cutting the price target to CHF 132 from CHF 133. The firm left its positive view intact despite the trim. Market cap stands at $295,398,046,720 and the stock moved -2.61% (-$4.02) on the news. Meyka AI rates NVS with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.